Scott Huennekens joins 270Surgical Board of Directors, Observer and Advisor
NETANYA, Israel and DALLAS, Jan. 26, 2021 -- (Healthcare Sales & Marketing Network) -- 270Surgical Ltd is pleased to announce that Scott Huennekens has joined the Board of Directors team as an Observer and will also act as an advisor to the Board and CEO ... Devices, Surgery, Personnel 270Surgical, SurroundScope, laparoscope, laparoscopic camera (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 26, 2021 Category: Pharmaceuticals Source Type: news

Connect Biopharma Strengthens Leadership Team with Key Hire
New Chief Business Officer joins company as part of organizational growth strategy SAN DIEGO and TAICANG, SUZHOU, China, Jan. 26, 2021 -- (Healthcare Sales & Marketing Network) -- Connect Biopharma, a global clinical-stage biopharmaceutical company ded... Biopharmaceuticals, Personnel Connect Biopharma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 26, 2021 Category: Pharmaceuticals Source Type: news

BD Names CEO Tom Polen as Chairman of the Board
Polen to Succeed Vince Forlenza Effective April 28 FRANKLIN LAKES, N.J., Jan. 26, 2021 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Tom Polen, ... Devices, Personnel BD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 26, 2021 Category: Pharmaceuticals Source Type: news

The Henry Ford Cancer Institute Installs its Second ViewRay MRIdian(R) Linac
Second MRIdian System to be Installed at Henry Ford Health System's New Cancer Pavilion in Detroit CLEVELAND, Jan. 26, 2021 -- (Healthcare Sales & Marketing Network) -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Henry Ford Cancer Institute has i... Devices, Oncology ViewRay, MRIdian, MRI-guided radiation therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 26, 2021 Category: Pharmaceuticals Source Type: news

PEDRA(TM) Technology Receives FDA Breakthrough Device Designation for its PEDRA(TM) Xauron(TM) Real-Time Tissue Perfusion System
Novel perfusion monitor achieves FDA Breakthrough Device Designation for real-time, periprocedural monitoring of tissue perfusion in patients with critical limb threatening ischemia SINGAPORE, Jan 25, 2021 -- (Healthcare Sales & Marketing Network) -- P... Devices, Monitoring, FDA PEDRA Technology, tissue perfusion, Xauron, critical limb ischemia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 25, 2021 Category: Pharmaceuticals Source Type: news

Candela announces the launch of the Frax Pro(TM) system, the smart way to Frax
A 50-year legacy of innovation and a continued commitment to Science. Results. Trust. MARLBOROUGH, Mass., Jan. 25, 2021 -- (Healthcare Sales & Marketing Network) -- Candela, a leading global medical aesthetic device company, today announced the availab... Devices, Dermatology, Product Launch Candela , Frax Pro, skin resurfacing, Frax 1550, Frax 1940 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 25, 2021 Category: Pharmaceuticals Source Type: news

FDA Approves Theranica's Nerivio(R) for Acute Treatment of Migraine in Adolescents
VThe Prescribed Wearable Device is Now indicated for Patients 12 Years Old and Above NETANYA, Israel and MONTCLAIR, N.J., Jan. 25, 2021 -- (Healthcare Sales & Marketing Network) -- Theranica, a prescribed digital therapeutics (PDT) company developing a... Devices, Neurology, FDA Theranica , prescribed digital therapeutics, Nerivio , migraine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 25, 2021 Category: Pharmaceuticals Source Type: news

OrthoSpin Ltd. Receives FDA Regulatory Clearance for its G2 System
YOKNEAM, Israel, Jan. 25, 2021 -- (Healthcare Sales & Marketing Network) -- OrthoSpin Ltd. ("OrthoSpin"), announced today that it received regulatory clearance from the United States Food and Drug Administration (FDA) for its second generation, ... Devices, Orthopaedic, FDA OrthoSpin, external fixation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 25, 2021 Category: Pharmaceuticals Source Type: news

Eiger BioPharmaceuticals Announces U.S. Commercial Availability of Zokinvy(TM) (lonafarnib), the First and Only Treatment Approved for Progeria and Processing-Deficient Progeroid Laminopathies
The Eiger OneCare™ Program Provides Ongoing Patient Support Services PALO ALTO, Calif., Jan. 25, 2021 -- (Healthcare Sales & Marketing Network) -- Eiger BioPharmaceuticals, Inc (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the ... Biopharmaceuticals, Product Launch Eiger BioPharmaceuticals, Zokinvy, lonafarnib, Progeria (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 25, 2021 Category: Pharmaceuticals Source Type: news

Lilly Completes Acquisition of Prevail Therapeutics
INDIANAPOLIS, Jan. 22, 2021 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE:LLY) today announced the successful completion of its acquisition of Prevail Therapeutics Inc. (NASDAQ: PRVL). The acquisition establishes a new modality ... Biopharmaceuticals, Neurology, Mergers & Acquisitions Eli Lilly, Prevail Therapeutics, Parkinson's disease, Gaucher disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2021 Category: Pharmaceuticals Source Type: news

Boston Scientific Receives FDA Approval For The Vercise Genus(TM) Deep Brain Stimulation System
Fourth-generation DBS portfolio features full-body MR conditional devices MARLBOROUGH, Mass., Jan. 22, 2021 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) appr... Devices, Neurology, FDA Boston Scientific, Vercise Genus, Deep Brain Stimulation, Parkinson's disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2021 Category: Pharmaceuticals Source Type: news

BiondVax Announces Appointment of Amir Reichman as New CEO
Pharma Industry Veteran in Vaccines will Assume Role Full Time March 2, 2021, with Focus on Developing Product Pipeline in Infectious Diseases JERUSALEM, Jan. 21, 2021 -- (Healthcare Sales & Marketing Network) -- BiondVax Pharmaceuticals Ltd. (Nasdaq: ... Biopharmaceuticals, Personnel BiondVax Pharmaceuticals, influenza, vaccine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 21, 2021 Category: Pharmaceuticals Source Type: news

Boston Scientific Announces Agreement To Acquire Preventice Solutions, Inc.
Acquisition of external cardiac monitoring technologies and services provider to expand rhythm management diagnostics portfolio and capabilities MARLBOROUGH, Mass., Jan. 21, 2021 -- (Healthcare Sales & Marketing Network) -- Boston Scientific (NYSE: BSX... Devices, Monitoring, Cardiology, Mergers & Acquisitions Boston Scientific, Preventice Solutions, cardiac monitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 21, 2021 Category: Pharmaceuticals Source Type: news

MIVI Neuroscience Secures Series B Funding
EDEN PRAIRIE, Minn., Jan. 21, 2021 -- (Healthcare Sales & Marketing Network) -- MIVI Neuroscience, a medical device company focused on improving clinical outcomes for ischemic stroke patients, today announced the closing of its Series B funding including ... Devices, Interventional, Neurology, Venture Capital MIVI Neuroscience, Q Aspiration System, DAISe , Thrombectomy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 21, 2021 Category: Pharmaceuticals Source Type: news

Abbott Receives Expanded Medicare Reimbursement for First-Of-Its-Kind MitraClip(TM) Device
New national reimbursement enables access to transcatheter mitral valve repair procedures with MitraClip for people with secondary mitral regurgitation, significantly expanding the eligible patient population ABBOTT PARK, Ill., Jan. 20, 2021 -- (Healthc... Devices, Interventional, Cardiology, Reimbursement Abbott, MitraClip, mitral regurgitation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 20, 2021 Category: Pharmaceuticals Source Type: news

Haemonetics To Acquire Cardiva Medical, Inc. To Expand Hospital Portfolio
Enhances penetration into the large and growing interventional cardiology and electrophysiology markets Offers products with demonstrated and differentiated clinical benefits Expected to be accretive to revenue growth, gross margins and adjusted gros... Devices, Mergers & Acquisitions Haemonetics, Cardiva Medical (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 20, 2021 Category: Pharmaceuticals Source Type: news

Doptelet(R) (avatrombopag) approved in the EU for treatment of ITP
STOCKHOLM, Jan. 20, 2021 -- (Healthcare Sales & Marketing Network) -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) today announces that the European Commission (EC) has approved an extension of the indication for Doptelet (avatrombopag) to includ... Biopharmaceuticals, Regulatory Swedish Orphan Biovitrum, Sobi , Doptelet, avatrombopag (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 20, 2021 Category: Pharmaceuticals Source Type: news

Eitan Medical Receives FDA Clearance for Upgraded Sapphire(TM) Infusion Pump System
Upgraded Rev15 Sapphire™ Infusion System Provides Advanced Performance and Customization Capabilities Within Hospital, Pre-Hospital and Ambulatory Environments NETANYA, Israel, Jan. 19, 2021 -- (Healthcare Sales & Marketing Network) -- Eitan Medical, a... Devices, FDA Eitan Medical, Sapphire, Infusion Pump (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 19, 2021 Category: Pharmaceuticals Source Type: news

Theranica Adds Digital Therapeutics Expert Donald Jones to its Board of Directors
Appointment Comes as Demand for Migraine Therapeutic Wearable Nerivio® Expands in the U.S. NETANYA, Israel and MONTCLAIR, N.J., Jan. 19, 2021 -- (Healthcare Sales & Marketing Network) -- Theranica, a prescribed digital therapeutics (PDT) company d... Devices, Personnel Theranica, digital therapeutics, Nerivio, migraine, electroceutical (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 19, 2021 Category: Pharmaceuticals Source Type: news

GT Biopharma Appoints Two New Independent Directors
BEVERLY HILLS, Calif., Jan. 19, 2021 -- (Healthcare Sales & Marketing Network) -- GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative therapies based on the Company's proprietary NK cell engager (TriKE™) technology ... Biopharmaceuticals, Oncology, Personnel GT Biopharma, TriKE, NK cells (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 19, 2021 Category: Pharmaceuticals Source Type: news

Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies
INDIANAPOLIS and UTRECHT, The Netherlands, Jan. 19, 2021 -- (Healthcare Sales & Marketing Network) -- Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), and Merus N.V. (NASDAQ: MRUS), a clinical-stage oncology c... Biopharmaceuticals, Oncology Eli Lilly, Loxo Oncology, Merus NV (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 19, 2021 Category: Pharmaceuticals Source Type: news

Occlutech's Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Designation for Heart Failure (HF)
SCHAFFHAUSEN, Switzerland, Jan. 19, 2021 -- (Healthcare Sales & Marketing Network) -- Occlutech, a privately-held company, announced today that the U.S Food and Drug Administration (FDA) has granted the Company a Breakthrough Device designation for its fi... Devices, Cardiology, FDA Occlutech, Atrial Flow Regulator, heart failure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 19, 2021 Category: Pharmaceuticals Source Type: news

Vera Therapeutics Launches with $80 Million Series C Financing to Develop Phase 2b Novel Biologic for Kidney Disease
Potential first-in-class disease-modifying biologic in late-stage clinical studies Experienced executive development team from Gilead Sciences SOUTH SAN FRANCISCO, Calif., Jan. 19, 2021 -- (Healthcare Sales & Marketing Network) -- Vera Therapeutics,... Biopharmaceuticals, Venture Capital Vera Therapeutics, atacicept (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 19, 2021 Category: Pharmaceuticals Source Type: news

New Treatment for Severe Emphysema Now Covered Under Highmark Blue Cross Blue Shield
Spiration ® Valve System COPD Treatment Available to Highmark Blue Cross Blue Shield Members in Delaware, Pennsylvania, and West Virginia CENTER VALLEY, Pa., Jan. 18, 2021 -- (Healthcare Sales & Marketing Network) -- Olympus announced that Highmark... Devices, Reimbursement Olympus, Spiration, emphysema, COPD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2021 Category: Pharmaceuticals Source Type: news

Valeo Pharma Announces Major Addition to its Senior Management Team
Frederic Fasano named President and COO Steve Saviuk continues as CEO and becomes Vice-Chairman of the Board of Directors MONTREAL, Jan. 18, 2021 -- (Healthcare Sales & Marketing Network) - Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (&qu... Biopharmaceuticals, Personnel Valeo Pharma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2021 Category: Pharmaceuticals Source Type: news

Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy
BEDMINSTER, N.J. and SINGAPORE, Jan. 18, 2021 -- (Healthcare Sales & Marketing Network) -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, toda... Biopharmaceuticals, Oncology, Regulatory Tessa Therapeutics, CAR-T therapy, Hodgkin Lymphoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2021 Category: Pharmaceuticals Source Type: news

NeuroOne Medical Technologies Corporation Closes $12.5 Million Private Placement with Certain Prominent Institutional Investors, Advances Towards Nasdaq Uplisting
EDEN PRAIRIE, Minn., Jan. 15, 2021 -- (Healthcare Sales & Marketing Network) -- NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for pati... Devices, Neurology, Venture Capital NeuroOne Medical Technologies, Evo Cortical Electrode, functional mapping (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 15, 2021 Category: Pharmaceuticals Source Type: news

Lilly Announces $30 Million Limited Partner Investment in Unseen Capital Health Fund
Fund will provide support for minority-owned early-stage healthcare companies and is a component of Lilly's racial justice efforts INDIANAPOLIS, Jan. 15, 2021 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) today announce... Biopharmaceuticals, Venture Capital Eli Lilly (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 15, 2021 Category: Pharmaceuticals Source Type: news

SML Genetree Receives FDA Emergency Use Authorization for Ezplex SARS-CoV-2 G Real-Time PCR Kit with Specimen Pooling Capability
SANTA CLARA, Calif., Jan. 14, 2021 -- (Healthcare Sales & Marketing Network) -- SML Genetree announced today that it has received Emergency Use Authorization (EUA) from the U.S. FDA for the use of its Ezplex SARS-CoV-2 G Kit, a molecular diagnostic test f... Diagnostics, FDA SML Genetree, Ezplex, SARS-CoV-2, Real-Time PCR, COVID-19 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 14, 2021 Category: Pharmaceuticals Source Type: news

Abbott to Launch the NeuroSphere(TM) myPath(TM) Digital Health App Designed to Track and Report Pain Relief in Chronic Pain Patients With Physicians Prior to Device Implant
New app will allow patients to record their pain relief during the device trial period with spinal cord stimulation or dorsal root ganglion therapy, simplify reporting outcomes and connect patients to physicians who have real-time access to this data Ne... Devices, Neurology, Monitoring, Product Launch Abbott, NeuroSphere, myPath, spinal cord stimulation, neuromodulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 14, 2021 Category: Pharmaceuticals Source Type: news

Nonin Medical Announces New Full Board of Directors
Healthcare Industry Leaders to Support Company's Next Phase of Growth MINNEAPOLIS, Jan. 14, 2021 -- (Healthcare Sales & Marketing Network) -- Nonin Medical announced the appointment of four new members to the company's board of directors. Each of the n... Devices, Monitoring, Personnel Nonin Medical, pulse oximeter, cerebral oximeter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 14, 2021 Category: Pharmaceuticals Source Type: news

EVOQ Therapeutics Announces a License And Collaboration Agreement with Amgen
ANN ARBOR, Mich., Jan. 13, 2021 -- (Healthcare Sales & Marketing Network) -- EVOQ Therapeutics today announced a license and collaboration agreement with Amgen for the discovery and development of novel drugs for autoimmune disorders. Under the terms of t... Biopharmaceuticals, Licensing EVOQ Therapeutics, Amgen (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 13, 2021 Category: Pharmaceuticals Source Type: news

Conventus-Flower Announces New Executive Vice President of Marketing and RandD
MINNEAPOLIS, Jan. 12, 2021 -- (Healthcare Sales & Marketing Network) -- Conventus-Flower Orthopedics is poised to become a formidable orthopedic company focused on solving significant problems for patients and surgeons. Achieving our goal requires except... Devices, Orthopaedic, Personnel Conventus-Flower Orthopedics, proximal humerus, distal radius, nitinol CAGE (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 12, 2021 Category: Pharmaceuticals Source Type: news

Delfi Diagnostics Announces $100 Million Series A Financing to Develop a New Class of Early Detection Liquid Biopsy for Multiple Cancers
Novel liquid biopsy technology combines machine learning and low-cost cell free DNA genome-wide fragmentation profiles BALTIMORE, Jan. 12, 2021 -- (Healthcare Sales & Marketing Network) -- Delfi Diagnostics, Inc., a pioneering developer of a new class ... Diagnostics, Oncology, Venture Capital Delfi Diagnostics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 12, 2021 Category: Pharmaceuticals Source Type: news

Lower-Profile Web Intrasaccular Aneurysm Treatment Device Receives FDA Approval
The WEB™ Aneurysm Embolization System expands with a lower profile delivery system and new size configurations. ALISO VIEJO, Calif., Jan. 12, 2021 -- (Healthcare Sales & Marketing Network) -- MicroVention, Inc., a U.S.-based subsidiary of Terumo and a ... Devices, Neurosurgery, FDA MicroVention, Terumo, WEB 17 System, WEB Aneurysm Embolization (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 12, 2021 Category: Pharmaceuticals Source Type: news

MedSkin Solutions Dr. Suwelack AG Receives FDA 510(k) Clearance for MatriDerm(R) - Its Three-Dimensional Acellular Collagen Elastin Dermal Matrix Portfolio
MedSkin Solutions Dr. Suwelack AG announces receiving FDA 510(k) clearance for its flagship Med Care product portfolio MatriDerm® HAMBURG, Germany, Jan. 11, 2021 -- (Healthcare Sales & Marketing Network) -- MatriDerm® is a single-use three-dime... Devices, Dermatology, FDA MedSkin Solutions, MatriDerm, Dermal Matrix (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 11, 2021 Category: Pharmaceuticals Source Type: news

Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs
Details of Initial Therapeutic Programs to be Shared at the 39th J.P. Morgan Healthcare Conference BOSTON, Jan. 11, 2021 -- (Healthcare Sales & Marketing Network) -- Valo Health LLC (Valo), the technology company working to transform the drug discovery... Biopharmaceuticals, Venture Capital Valo Health (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 11, 2021 Category: Pharmaceuticals Source Type: news

CytoSorbents Appoints James Komsa as Vice President - U.S. Sales and Marketing
Seasoned sales veteran from Medtronic tasked to build and lead U.S. commercialization infrastructure as CytoSorbents sells CytoSorb under U.S. FDA Emergency Use Authorization for COVID-19 and leverages FDA Breakthrough Designation for potential future U.S.... Devices, Personnel CytoSorbents, CytoSorb, blood purification (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 11, 2021 Category: Pharmaceuticals Source Type: news

Marizyme Announces the Use of DuraGraft(R) as the Standard-of-Care in Patients Undergoing Coronary Artery Bypass Surgery (CABG) at Vienna Heart Center North Floridsdorf
DuraGraft is a one-time intraoperative treatment used during vascular surgery to reduce the incidence of complications associated with graft failure JUPITER, Fla., Jan. 11, 2021 -- (Healthcare Sales & Marketing Network) -- Marizyme, Inc. (OTCQB: MRZM),... Devices, Cardiology Marizyme, DuraGraft, CABG (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 11, 2021 Category: Pharmaceuticals Source Type: news

Blacksmith Medicines Launches With Seed Funding and a Research Collaboration With Lilly
Blacksmith Medicines, a spin-out of Forge Therapeutics, is pioneering a novel metalloenzyme chemistry platform to create new immuno-oncology and inflammation medicines Research collaboration combines Blacksmith's innovative chemistry platform with Lilly... Biopharmaceuticals, Venture Capital Blacksmith Medicines, Eli Lilly, Forge Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 8, 2021 Category: Pharmaceuticals Source Type: news

Werewolf Therapeutics Completes $72 Million Series B Financing to Advance a Novel Class of Cancer Biotherapeutics to the Clinic
Financing accelerates Werewolf's pipeline of systemically delivered, conditionally activated INDUKINE™ molecules into clinical stage development and supports efforts to build a leading immuno-oncology drug discovery and development team CAMBRIDGE, Mass.... Biopharmaceuticals, Oncology, Venture Capital Werewolf Therapeutics, tumor microenvironment, PREDATOR protein (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 7, 2021 Category: Pharmaceuticals Source Type: news

Kira Pharmaceuticals Announces $53.5 Million Series B+ Financing to Advance LOGIC Drug Discovery Platform and Pipeline of Complement-targeted Therapies
CAMBRIDGE, Mass. and SUZHOU, China, Jan. 7, 2021 -- (Healthcare Sales & Marketing Network) -- Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announ... Biopharmaceuticals, Venture Capital Kira Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 7, 2021 Category: Pharmaceuticals Source Type: news

Veteran Biopharma Executive Dane D. Hallberg Launches MASORI Therapeutics
New company will leverage artificial intelligence to help clients in multiple sectors generate actionable market insights and create competitive advantage BETHESDA, Md., Jan. 7, 2021 -- (Healthcare Sales & Marketing Network) -- Veteran biopharma indust... Biopharmaceuticals MASORI Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 7, 2021 Category: Pharmaceuticals Source Type: news

Theolytics raises $6.8 million Series A round co-led by Epidarex Capital and Taiho Ventures to advance viral cancer therapies
OXFORD, England, Jan. 7, 2021 -- (Healthcare Sales & Marketing Network) -- Theolytics, a UK biotech harnessing viruses to combat cancer, today announced the closing of a US $6.8 million (UK £5 million) Series A round. The round was co-led by Epidare... Biopharmaceuticals, Oncology, Venture Capital Theolytics, oncolytic virus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 7, 2021 Category: Pharmaceuticals Source Type: news

Aethlon Medical Expands Leadership Team with Appointment of Chief Business Officer and Chief Medical Officer
Guy Cipriani brings over 17 years of biotech and pharma business development experience to his role as Senior Vice President and Chief Business Officer of Aethlon Steven LaRosa, M.D., with over 20 years of experience as a practicing physician and infect... Devices, Personnel Aethlon Medical, Hemopurifier (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 6, 2021 Category: Pharmaceuticals Source Type: news

Myeloid Therapeutics Launches with Over $50 Million in Financing and Two Clinical Trials
Myeloid's cell therapy harnesses the innate capabilities of myeloid lineage cells to fight cancer Scientific founders include world-renowned cell therapy & cancer experts Ronald Vale, Ph.D. and Siddhartha Mukherjee, M.D., D.Phil. Co-Founded by Thomas... Biopharmaceuticals, Oncology, Venture Capital Myeloid Therapeutics, lymphoma, glioblastoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 6, 2021 Category: Pharmaceuticals Source Type: news

Ultromics receives FDA Clearance for a first-of-kind solution in Echocardiography to help clinicians diagnose disease
EchoGo Pro is an AI service for automated identification of coronary artery disease FDA gives 510(K) clearance for EchoGo Pro, expanding the use of Ultromics' EchoGo service to support clinicians diagnosing coronary artery disease Every year in the U... Devices, Cardiology, Radiology, FDA Ultromics, EchoGo Pro, EchoGo Core, imaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 6, 2021 Category: Pharmaceuticals Source Type: news

Enveric Biosciences Appoints Dr. Marcus Schabacker to Board of Directors
Industry Veteran Brings Over Three Decades of Experience Across Global Healthcare Landscape NAPLES, Fla., Jan. 5, 2021 -- (Healthcare Sales & Marketing Network) -- Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"... Biopharmaceuticals, Personnel Enveric Biosciences, cannabinoid (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 5, 2021 Category: Pharmaceuticals Source Type: news

DURECT Corporation Appoints Two New Board Members
CUPERTINO, Calif., Jan. 5, 2021 -- (Healthcare Sales & Marketing Network) -- DURECT Corporation (Nasdaq: DRRX) today announced the appointment of two new members to its board of directors, Gail J. Maderis, MBA and Mohammad Azab, M.D., M. Sc., MBA, two sen... Biopharmaceuticals, Drug Delivery, Personnel DURECT, hepatitis, non-alcoholic steatohepatitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 5, 2021 Category: Pharmaceuticals Source Type: news

Sebela Pharmaceuticals Announces U.S. Launch of SUTAB(R) Tablets, An Alternative to Liquid Colonoscopy Preparation
SUTAB® Tablets with Active Sulfate Ingredients Is the First Tablet Colonoscopy Preparation to Receive FDA Approval in Over 10 Years ROSWELL, Ga., Jan. 5, 2021 -- (Healthcare Sales & Marketing Network) -- Sebela Pharmaceuticals® today announced ... Biopharmaceuticals, Gastroenterology, FDA, Product Launch Sebela Pharmaceuticals, SUTAB , colonoscopy preparation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 5, 2021 Category: Pharmaceuticals Source Type: news